[July 29, 2016]

Global Metal Ion Chelators Pipeline Insights Report 2016 - Research and Markets

Research and Markets has announced the addition of the "Metal Ion Chelators - Pipeline Insights, 2016" report to their offering.

Metal Ion Chelators - Pipeline Insights, 2016, provides in-depth insights on the pipeline drugs and their development activities around the Metal Ion Chelators. The report covers the product profiles in various stages of development, including Discovery, Pre-Clinical, IND, Phase I, Phase II, Phase III and Preregistration.

The report covers the product clinical trials information and other development activities, including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA (News - Alert) designations details.

The report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Metal Ion Chelators.

The report also assesses the Metal Ion Chelators therapeutics by Monotherapy, Combination Products, Molecule Type and Route of Administration.

Scope

• The report provides competitive pipeline landsape of Metal Ion Chelators
• The report provides pipeline products under drug profile section, which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Metal Ion Chelators pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Metal Ion Chelators and also provides company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

1. Overview
2. Pipeline Therapeutics
3. Therapeutics under Development by Companies
4. Filed and Phase III Products
5. Comparative Analysis
6. Phase II Products
7. Comparative Analysis
8. Phase I and IND Filed Products
9. Comparative Analysis
10. Discovery and Pre-Clinical Stage Products
11. Comparative Analysis
12. Drug Candidate Profiles
13. Therapeutics Assessment
14. Assessment by Monotherapy Products
15. Assessment by Combination Products
16. Assessment by Route of Administration
17. Assessment by Molecule Type
18. Discontinued Products
19. Dormant Products
20. Companies Involved in Therapeutics Development

For more information visit http://www.researchandmarkets.com/research/hgdbq6/metal_ion.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160729005818/en/

[ Back To TMCnet.com's Homepage ]